Unknown PHASE2 INTERVENTIONAL 1-arm NCT00594529

Feasibility Study of Neoadjuvant Chemotherapy Modified FOLFOX6 for Resectable Liver Metastases of Colorectal Cancers

Sponsor: Kyoto University

Conditions Colorectal Cancer Liver Metastasis

Interventions Surgery

Updated 6 times since 2017 Last updated: Jun 22, 2011 Started: Jan 31, 2008 Primary completion: May 31, 2010 Completion: May 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Colorectal Cancer and Liver Metastasis, this trial is ongoing. The trial is conducted by Kyoto University and has accumulated 6 data snapshots since 2008. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jun 2023 — Jul 2024 [monthly]

Unknown Status PHASE2
Jan 2021 — Jun 2023 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kyoto University

Data source: Kyoto University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kyoto, Japan